David B. Fischer - 03 Dec 2025 Form 4 Insider Report for BALCHEM CORP (BCPC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Dec 2025, 16:28:08 UTC
Prior SEC filing
02 Oct 2025
Next SEC filing
09 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Travis Larsen, Attorney in Fact for David B Fischer

Key filing fact

David B. Fischer filed Form 4 for BALCHEM CORP (BCPC) on 05 Dec 2025.

Key facts

  • This page summarizes David B. Fischer's Form 4 filing for BALCHEM CORP (BCPC).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Dec 2025, 16:28.

Change

  • Previous filing in this sequence was filed on 02 Oct 2025.
  • Current net transaction value: -$759,414.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001305182 Primary reporting owner

Fischer David B

Relationship
Director
Address
C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE
Signature
/s/ Travis Larsen, Attorney in Fact for David B Fischer
Signature date
05 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Options Exercise

Transaction value
$252,270
Shares
+3,383
Change %
+34%
Price
$74.57
Shares after
13,372
Date
03 Dec 2025
Ownership
Direct
Footnotes
F1
BCPC transaction

Common Stock

Options Exercise

Transaction value
$220,064
Shares
+2,617
Change %
+20%
Price
$84.09
Shares after
15,989
Date
03 Dec 2025
Ownership
Direct
Footnotes
F1
BCPC transaction

Common Stock

Sale

Transaction value
$923,458
Shares
-6,000
Change %
-38%
Price
$153.91
Shares after
9,989
Date
03 Dec 2025
Ownership
Direct
Footnotes
F2
BCPC transaction

Common Stock

Sale

Transaction value
$308,291
Shares
-2,000
Change %
-20%
Price
$154.15
Shares after
7,989
Date
03 Dec 2025
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCPC transaction Derivative

Stock Options

Options Exercise

Transaction value
$0
Shares
-3,383
Change %
-100%
Price
$0.000000
Shares after
0
Date
03 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,383
Exercise price
$74.57
Footnotes
F4
BCPC transaction Derivative

Stock Options

Options Exercise

Transaction value
$0
Shares
-2,617
Change %
-100%
Price
$0.000000
Shares after
0
Date
03 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,617
Exercise price
$84.09
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Exercise of fully vested non-qualified stock options.

Footnote F2

This transaction was executed in multiple sales ranging from $153.5100 to $154.2400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

Footnote F3

This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

Footnote F4

Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.

Footnote F5

Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .